256 related articles for article (PubMed ID: 16391868)
1. Tumor cell dissemination in colon cancer does not predict extrahepatic recurrence in patients undergoing surgery for hepatic metastases.
Schoppmeyer K; Frühauf N; Oldhafer K; Seeber S; Kasimir-Bauer S
Oncol Rep; 2006 Feb; 15(2):449-54. PubMed ID: 16391868
[TBL] [Abstract][Full Text] [Related]
2. Urokinase-plasminogen-activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer.
Thomas C; Wiesner C; Melchior SW; Schmidt F; Gillitzer R; Thüroff JW; Pfitzenmaier J
BJU Int; 2009 Jul; 104(1):29-34. PubMed ID: 19154451
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of different markers in non-small cell lung cancer: prognostic value of clinical staging, tumour cell detection and tumour marker analysis for tumour progression and overall survival.
Kasimir-Bauer S; Schleucher N; Weber R; Neumann R; Seeber S
Oncol Rep; 2003; 10(2):475-82. PubMed ID: 12579292
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
[TBL] [Abstract][Full Text] [Related]
5. Urokinase plasminogen activator receptor (uPA-R): one potential characteristic of metastatic phenotypes in minimal residual tumor disease.
Allgayer H; Heiss MM; Riesenberg R; Grützner KU; Tarabichi A; Babic R; Schildberg FW
Cancer Res; 1997 Apr; 57(7):1394-9. PubMed ID: 9102229
[TBL] [Abstract][Full Text] [Related]
6. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
D'Amico TA; Brooks KR; Joshi MB; Conlon D; Herndon J; Petersen RP; Harpole DH
Ann Thorac Surg; 2006 Jun; 81(6):1982-7; discussion 1987. PubMed ID: 16731117
[TBL] [Abstract][Full Text] [Related]
7. Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases.
Yoon SS; Kim SH; Gonen M; Heffernan NM; Detwiller KY; Jarnagin WR; D'Angelica M; Blumgart LH; Tanabe KK; Dematteo RP
Ann Surg Oncol; 2006 Mar; 13(3):353-62. PubMed ID: 16474912
[TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].
Zhou Q; Liang LJ; Peng BG; Zhen YY
Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916
[TBL] [Abstract][Full Text] [Related]
9. Cancer cell dissemination during curative surgery for colorectal liver metastases.
Topal B; Aerts JL; Roskams T; Fieuws S; Van Pelt J; Vandekerckhove P; Penninckx F
Eur J Surg Oncol; 2005 Jun; 31(5):506-11. PubMed ID: 15922887
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of epidermal growth factor receptor expression in colon cancer patients undergoing curative surgery.
Galizia G; Lieto E; Ferraraccio F; De Vita F; Castellano P; Orditura M; Imperatore V; La Mura A; La Manna G; Pinto M; Catalano G; Pignatelli C; Ciardiello F
Ann Surg Oncol; 2006 Jun; 13(6):823-35. PubMed ID: 16614884
[TBL] [Abstract][Full Text] [Related]
11. Detection of disseminated tumour cells in blood and bone marrow samples of patients undergoing hepatic resection for metastasis of colorectal cancer.
Vlems FA; Diepstra JH; Punt CJ; Ligtenberg MJ; Cornelissen IM; van Krieken JH; Wobbes T; van Muijen GN; Ruers TJ
Br J Surg; 2003 Aug; 90(8):989-95. PubMed ID: 12905553
[TBL] [Abstract][Full Text] [Related]
12. Detection of disseminated tumor cells in liver biopsies of colorectal cancer patients is not associated with a worse prognosis.
Koch M; Kienle P; Logan E; Antolovic D; Galindo L; Schmitz-Winnenthal FH; Schmidt J; Herfarth C; Weitz J
Ann Surg Oncol; 2007 Feb; 14(2):810-7. PubMed ID: 17103077
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of hepatic CEA+ cells: hepatic tumor cell dissemination in colorectal cancer patients--limits of surgery?
Rehders A; Stoecklein NH; Aydin F; Alexander A; Baldus SE; Knoefel WT
Cancer Invest; 2010 May; 28(4):381-6. PubMed ID: 20370424
[TBL] [Abstract][Full Text] [Related]
14. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
15. Rare expression of target antigens for immunotherapy on disseminated tumor cells in breast cancer patients without overt metastases.
Kasimir-Bauer S; Otterbach F; Oberhoff C; Schmid KW; Kimmig R; Seeber S
Int J Mol Med; 2003 Dec; 12(6):969-75. PubMed ID: 14612976
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
17. Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans.
Grøndahl-Hansen J; Ralfkiaer E; Kirkeby LT; Kristensen P; Lund LR; Danø K
Am J Pathol; 1991 Jan; 138(1):111-7. PubMed ID: 1702928
[TBL] [Abstract][Full Text] [Related]
18. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
Holm NT; Byrnes K; Li BD; Turnage RH; Abreo F; Mathis JM; Chu QD
J Surg Res; 2007 Jul; 141(1):53-9. PubMed ID: 17574038
[TBL] [Abstract][Full Text] [Related]
19. Increased urokinase-type plasminogen activator receptor and epidermal growth factor receptor in serum of patients with prostate cancer.
Milanese G; Dellabella M; Fazioli F; Pierpaoli E; Polito M; Siednius N; Montironi R; Blasi F; Muzzonigro G
J Urol; 2009 Mar; 181(3):1393-400. PubMed ID: 19157433
[TBL] [Abstract][Full Text] [Related]
20. Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1cm rule.
Hamady ZZ; Cameron IC; Wyatt J; Prasad RK; Toogood GJ; Lodge JP
Eur J Surg Oncol; 2006 Jun; 32(5):557-63. PubMed ID: 16580811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
